Termination of Clozapine Treatment Due to Medical Reasons: When Is It Warranted and How Can It Be Avoided?NIELSEN, Jimmi; CORRELL, Christoph U; MANU, Peter et al.The Journal of clinical psychiatry. 2013, Vol 74, Num 6, pp 603-613, issn 0160-6689, 11 p.Article

Erroneous Administration of Clozapine in a Very Elderly PatientPALMIERE, Cristian; MANGIN, Patrice.Journal of clinical psychopharmacology. 2011, Vol 31, Num 1, pp 122-123, issn 0271-0749, 2 p.Article

Successful Rechallenge With Clozapine After EosinophiliaROBERTS, Catherine E; YOUNG MORTENSON, Lindsey; MERRILL, David B et al.The American journal of psychiatry. 2011, Vol 168, Num 11, pp 1147-1151, issn 0002-953X, 5 p.Article

Resistant-schizophrenia after discontinuation of clozapine: Report of two casesLAMIA, Dellagi; BEN AZOUZ OLFA; INES, Johnson et al.Progress in neuro-psychopharmacology & biological psychiatry. 2009, Vol 33, Num 8, pp 1553-1554, issn 0278-5846, 2 p.Article

Clozapine : Iléus = Clozapine : IleusLa Revue Prescrire. 2007, Vol 27, Num 290, pp 907-907, issn 0247-7750, 1 p.Article

Ocular pigmentation associated with clozapineBOROVIK, Armand M; BOSCH, Martina M; WATSON, Stephanie L et al.Medical journal of Australia. 2009, Vol 190, Num 4, pp 210-211, issn 0025-729X, 2 p.Article

Clozapine-induced persistent paroxysmal perceptual alterationSAMIR KUMAR PRAHARAJ; SAMAL, Abhisek; SARKHEL, Sujit et al.Progress in neuro-psychopharmacology & biological psychiatry. 2010, Vol 34, Num 6, pp 1151-1152, issn 0278-5846, 2 p.Article

Augmenting Clozapine With Sertindole: A Double-Blind, Randomized, Placebo-Controlled StudyNIELSEN, Jimmi; EMBORG, Charlotte; ANDERSEN, Torben et al.Journal of clinical psychopharmacology. 2012, Vol 32, Num 2, pp 173-178, issn 0271-0749, 6 p.Article

A Case of Agranulocytosis Secondary to Rechallenge With Clozapine Following Severe Neutropenia During Previous TherapyLERTXUNDI, Unax; SANCHEZ, Pedro; HERNANDEZ, Rafael et al.The Journal of clinical psychiatry. 2011, Vol 72, Num 12, issn 0160-6689, p. 1659Article

Inhibition of recombinant Ca_v3.1 (α_1G) T-type calcium channels by the antipsychotic drug clozapineCHOI, Kee-Hyun; RHIM, Hyewhon.European journal of pharmacology. 2010, Vol 626, Num 2-3, pp 123-130, issn 0014-2999, 8 p.Article

Clozapine, GABA_B, and theTreatment of Resistant SchizophreniaDASKALAKIS, Z. J; GEORGE, T. P.Clinical pharmacology and therapeutics. 2009, Vol 86, Num 4, pp 442-446, issn 0009-9236, 5 p.Article

Successful re-exposure to clozapine following uneventful rechallenge with olanzapine in a patient with neutropenia related to both agentsWU, Szu-Ying; LIU, Chen-Chung; HSIEH, Ming H et al.Progress in neuro-psychopharmacology & biological psychiatry. 2008, Vol 32, Num 4, pp 1089-1090, issn 0278-5846, 2 p.Article

Treatment Pathway and Patterns of Clozapine Prescribing for Schizophrenia in New ZealandWHEELER, Amanda J.The Annals of pharmacotherapy. 2008, Vol 42, Num 6, pp 852-860, issn 1060-0280, 9 p.Article

Continuation of Clozapine During Chemotherapy: A Case Report and Review of LiteratureCUNNINGHAM, Natasha T; DENNIS, Nora; DATTILO, Wilbur et al.Psychosomatics (Washington, DC). 2014, Vol 55, Num 6, pp 673-679, issn 0033-3182, 7 p.Article

Rapid clozapine titration in treatment-refractory bipolar disorderIFTENI, Petru; CORRELL, Christoph U; NIELSEN, Jimmi et al.Journal of affective disorders. 2014, Vol 166, pp 168-172, issn 0165-0327, 5 p.Article

Effects of Clozapine on Heart Rate Dynamics and Their Relationship With Therapeutic Response in Treatment-Resistant SchizophreniaKIM, Jong-Hoon; SANG HOON YI; LEE, Jinyoung et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 1, pp 69-73, issn 0271-0749, 5 p.Article

A review of the use of clozapine levels to guide treatment and determine cause of deathSTARK, Anne; SCOTT, James.Australian and New Zealand journal of psychiatry. 2012, Vol 46, Num 9, pp 816-825, issn 0004-8674, 10 p.Article

Pregabalin-Associated Increase of Clozapine Serum LevelsENGLISCH, Susanne; ALM, Barbara; MEYER-LINDENBERG, Andreas et al.Journal of clinical psychopharmacology. 2012, Vol 32, Num 1, issn 0271-0749, p. 127Article

Augmentation of clozapine with a second antipsychotic - a meta-analysisTAYLOR, D. M; SMITH, L; GEE, S. H et al.Acta psychiatrica scandinavica. 2012, Vol 125, Num 1, pp 15-24, issn 0001-690X, 10 p.Article

Clozapine-Induced Agranulocytosis in Finland, 1982―2007: Long-Term Monitoring of Patients Is Still WarrantedLAHDELMA, Liisa; APPELBERG, Björn.The Journal of clinical psychiatry. 2012, Vol 73, Num 6, pp 837-842, issn 0160-6689, 6 p.Article

Predictors of Clozapine Response in Patients With Treatment-Refractory Schizophrenia: Results From a Danish Register StudyNIELSEN, Jimmi; ERNST NIELSEN, Rene; CORRELL, Christoph U et al.Journal of clinical psychopharmacology. 2012, Vol 32, Num 5, pp 678-683, issn 0271-0749, 6 p.Article

Usefulness of NT-Pro-BNP and Echocardiography in the Diagnosis of Subclinical Clozapine-Related CardiotoxicityROSTAGNO, Carlo; DOMENICHETTI, Sandro; PASTORELLI, Francesca et al.Journal of clinical psychopharmacology. 2011, Vol 31, Num 6, pp 712-716, issn 0271-0749, 5 p.Article

Clozapine Rechallenge Following Clozapine-Induced PericarditisCREWS, Matthieu P. K; DHILLON, Gurbinder S; MACCABE, James H et al.The Journal of clinical psychiatry. 2010, Vol 71, Num 7, pp 959-961, issn 0160-6689, 3 p.Article

Extensive elevation of creatine kinase with generic clozapine, but not with LeponexSCHENNACH-WOLFF, Rebecca; STÜBNER, Susanne; RIEDEL, Michael et al.Psychiatry research (Print). 2010, Vol 176, Num 1, issn 0165-1781, p. 93Article

Where to Position Clozapine: Re-examining the EvidenceAGID, Ofer; FOUSSIAS, George; SINGH, Shayna et al.Canadian journal of psychiatry. 2010, Vol 55, Num 10, pp 677-684, issn 0706-7437, 8 p.Article